The Role of p53 Gene In Molecular Pathogenesis of Oral Squamous Cell Carcinoma
DOI:
https://doi.org/10.46862/interdental.v21i2.9906Keywords:
Oral squamous cell carcinoma, p53 mutation, oral carcinogenesisAbstract
Introduction: Oral squamous cell carcinoma is the most common malignant tumor in oral and originates from the epithelial tissue. Carcinoma formation is a genetic process that triggers changes in cell morphology and behavior. Abnormalities in cell cycle control, regulated by p53 among these factors. This study was conducted to examine the role of p53 and p53-related proteins in the formation of oral squamous cell carcinoma.
Review: p53 is a component of the genome associated with the development of cancer in humans. Several studies have suggested that p53 is an important antitumor weapon. In the cell cycle, p53 is recognized if there is a cell mutation or the presence of an oncogene, and delays the cell cycle to prevent cells from becoming cancerous. The level of p53 will increase and react by arresting the cell cycle, directing cells to repair or undergo apoptosis. If p53 does not function, the cell cycle carrying damaged genetic material continues and is unable to undergo apoptosis. As a result, cells continue to proliferate with genetic abnormalities that can lead to malignancy.
Conclusion: Loss of p53 function can cause random mutations, chromosomal changes, and aneuploidy, which drive the growth of cancer cells to a malignant state. Analysis of changes at the molecular level can be a major diagnostic tool to guide treatment and identify changes associated with oral squamous cell carcinoma.
Downloads
References
1. Krishna A, Singh S, Kumar V, Pal US. Molecular concept in human oral cancer. Natl J Maxillofac Surg 2015; 6(1): 9-15. Doi: 10.4103/0975-5950.168235
2. Liu, T. Squamous Cell Carcinoma of the Conjunctiva. In: Schmidt-Erfurth, U., Kohnen, T. (eds) Encyclopedia of Ophthalmology. Berlin, Heidelberg: Springer; 2018.
3. Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol 2015; 8(9): 11884-94.
4. Ettinger KS, Ganry L, Fernandes RP. Oral cavity cancer. Oral Maxillofac Surg Clin North Am 2019; 31(1): 13-29. Doi: 10.1016/j.coms.2018.08.002
5. Sapp JP EL, WG. Contemporary Oral and Maxillofacial Pathology. Chapter 6: Epithelial Disorders. 2nd edition. Maryland Heights MO: Mosby Year Book Inc; 2004.p.184-193.
6. Watters C, Brar S, Pepper T. Cancer of the oral mucosa. Treasure Island (FL): StatPearls Publishing; 2025.
7. Tan Y, Wang Z, Xu M, Li B, Huang Z, Qin S, Nice EC, Tang J, Huang C. Oral squamous cell carcinomas: State of the field and emerging directions. Int. J Oral Sci 2023; 15(1): 44. Doi: 10.1038/s41368-023-00249-w
8. Kumar M, Nanavati R, Modi TG, Dobariya C. Oral cancer: Etiology and risk factors: A review. Journal of Cancer Research and Therapeutics 2016; 12(2): 458-463. Doi: 10.4103/0973-1482.186696.
9. Jayasinghe RD, Siriwardena BSMS. Clinical aspects of oral cancer and potentially malignant disorders with special relevance to South Asia. Ann Maxillofac Surg 2024;14(2): 128-136. Doi: 10.4103/ams.ams_184_24.
10. Ferreira AK, Carvalho SH, Granville-Garcia AF, Sarmento DJ, Agripino GG, Abreu MH, Melo MC, Caldas AD Jr, Godoy GP. Survival and prognostic factors in patients with oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 2021; 26(3): e387-e392. Doi: 10.4317/medoral.24242.
11. Silva LC, Faustino ISP, Ramos JC, Colafemina ACE, Di Pauli-Paglioni M, Leite AA, Santos-Silva AR, Lopes MA, Vargas PA. The importance of early treatment of oral squamous cell carcinoma: Case report. Oral Oncol 2023; 144: 106333. Doi: 10.1016/j.oraloncology.2023.106442.
12. Constantin M, Chifiriuc MC, Bleotu C, Vrancianu CO, Cristian RE, Bertesteanu SV, Grigore R, Bertesteanu G. Molecular pathways and targeted therapies in head and neck cancers pathogenesis. Frontiers in Oncology 2024; 14: 1373821. Doi: 10.3389/fonc.2024.1373821.
13. Ravindran S, Ranganathan S, R K, J N, AS, Kannan SK, Prasad KD, Marri J, K R. The role of molecular biomarkers in the diagnosis, prognosis, and treatment stratification of oral squamous cell carcinoma: A comprehensive review. J Liq Biopsy 2025;7(1): 100285. Doi: 10.1016/j.jlb.2025.100285
14. Nair P, Deshmukh PD, Trivedi AM, Thomas JS. Oral cancer and genomics. Journal of the International Clinical Dental Research Organization 13(2): 6-92. Doi: 10.4103/jicdro.jicdro_23_21
15. Cabral LGdS, Martins IM, Paulo EPdA, Pomini KT, Poyet JL, Maria DA. Molecular mechanisms in the carcinogenesis of oral squamous cell carcinoma: A literature review. Biomolecules 2025; 15(5): 621. Doi: 10.3390/biom15050621
16. Karp G. Cell and Molecular biology. 2st ed. New York : John Wiley & son Inc; 1999.p.609-616, 710-3.
17. Zhang H, Xu J, Long Y, Maimaitijiang A, Su Z, Li W, Li J. Unraveling the guardian: p53’s multifaceted role in the dna damage response and tumor treatment strategies. Int J Mol Sci 2024; 25(23): 12928. Doi: 10.3390/ijms252312928
18. Katerji M, Duerksen-Hughes PJ. DNA damage in cancer development: special implications in viral oncogenesis. Am J Cancer Res 2021; 11(8): 3956-3979. PMID: 34522461;
19. Liu K, Zheng M, Lu R. et al. The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review. Cancer Cell Int 2020; 20(1): 213. Doi: 10.1186/s12935-020-01304-w
20. Shen J, Wang Q, Mao Y, Gao W, Duan S. Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies. MedComm (2020). 2023 May 28;4(3):e288. Doi: 10.1002/mco2.288
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Firyal Nabilla, Indra Hadikrishna, Harmas Yazid Yusuf
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
- Every manuscript submitted to must observe the policy and terms set by the Interdental Jurnal Kedokteran Gigi (IJKG)
- Publication rights to manuscript content published by the Interdental Jurnal Kedokteran Gigi (IJKG) is owned by the journal with the consent and approval of the author(s) concerned.
- Full texts of electronically published manuscripts can be accessed free of charge and used according to the license shown below.
